Overview

Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Bp Consulting, Inc
Treatments:
Anti-Inflammatory Agents, Non-Steroidal
Bromfenac
Nepafenac
Ophthalmic Solutions
Criteria
Inclusion Criteria:

- > 18 years old, either gender or any race.

- Diagnosis of open-angle glaucoma or ocular hypertension requiring laser
trabeculoplasty.

- Completion of written and informed consent/authorization prior to any study related
procedures.

- Able to follow study protocol and likely to complete study schedule.

Exclusion Criteria:

- Known sensitivity to NSAIDs.

- History of neovascular or ocular inflammatory disease.

- Current use of topical or systemic anti-inflammatory medications.

- Females of childbearing potential.